A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia

Hyperphosphatemia

A Study to Evaluate Safety and Efficacy of AP-306 in Hyperphosphatemia Patients Efficacy and Safety of Cholestyramine in the Management of Hyperphosphatemia in Adult Hemodialysis Patients Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants Effectiveness of The Phosphate Mobile App on Serum Phosphorus in Adult Hemodialysis Patients With Hyperphosphatemia Clinical Study of KHK7791 in Hyperphosphatemia Patients on Peritoneal Dialysis Clinical Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis Long-term Effects of the New Nordic Renal Diet in Patients With Moderate Chronic Kidney Disease A Phase 2 Study to Evaluate the Safety and Efficacy of VS-505 to Treat Hyperphosphatemia in Hemodialysis Patients Study to Evaluate the Use of Tenapanor as Core Therapy in the Treatment of Hyperphosphatemia Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate Powder The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET Scan A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis Effect of Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure (CKD) Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5D Low-Phosphate Diet and Fibroblast Growth Factor-23 Level A Study of Ferric Citrate to Improve Inflammation and Lipid Levels An Open Label Trial to Evaluate the Effects of a Novel Renal Multivitamin on Inflammation and Other Biomarkers in Endstage Renal Disease Patients Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease Decreasing Intakes & Absorption of Phosphorus in Haemodialysis Patients Through Food Choices A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Effects of Ferric Citrate in Subjects With End Stage Renal Disease Effect of Velphoro on Serum Phosphate and Albumin in Peritoneal Dialysis Patients A Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Investigate and Compare the Efficacy, Safety and Tolerability of Lanthanum Carbonate With Calcium Carbonate in Hyperphosphataemic Children and Adolescents With Chronic Kidney Disease on Dialysis A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients Not on Dialysis An Open Label Dose Titration of Sevelamer Carbonate Tabs 3 Times a Day in Hyperphosphatemic CKD Patients Not On Dialysis EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease) Therapeutic Equivalence of OsvaRen® Tablets and OsvaRen® Granules Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy Subjects PD Study to Assess Phosphate Binding Characteristics of K2CG Chewing Gum Phosphate Kinetic Modeling 2 Non-interventional Study to Evaluate the Ease of Reaching Individual Goals in Serum Phosphorus (Steering) A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE) Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis Placebo Versus SBR759 in Lowering Phosphate in Dialysis Patients Egg White for Phosphorus Control in Haemodialysis Patients An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Participants With Chronic Kidney Disease Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark Study Rate of Termination of Premixed Parenteral Nutrition (PN) in Surgical Patients Secondary to High Serum Electrolytes Long-term Extension Study of MCI-196 Arterial Stiffness and Calcifications in Haemodialysis Patients on Sevelamer or Calcium Acetate DS2330b Alone and With Sevelamer in Patients on Chronic Hemodialysis Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients Bioequivalence Study Comparing Calcium Acetate Oral Solution Versus Calcium Acetate Gelcaps in Healthy Volunteers Phosphorus Improvement Pilot Study Chewed vs. Crushed Lanthanum Carbonate in Hemodialysis Patients Behavioral Management of Phosphorus in Hemodialysis Patients A Safety and Tolerability Study of Zerenex (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD) A Dose Escalation Study of VS-505 in End Stage Renal Disease Patients Undergoing Hemodialysis A Long-Term Study to Evaluate the Ability of Tenapanor Alone or in Combination With Sevelamer to Treat to Goal Serum Phosphorus in Patients With End-Stage Kidney Disease on Dialysis Effect of Restriction of Foods Containing Phosphorus Additives Post Authorisation Safety Study of Renvela® in Chronic Kidney Disease Patients Not on Dialysis With Hyperphosphataemia The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis Patients Efficacy of Dietary Education and Education on Phosphate Binder Use in Hemodialysis Patients Bioequivalence Study of BAY77-1931 Granule Phosphate Microvascular Study Dose-finding Study of MCI-196 Study in Chronic Kidney Disease (CKD) Not on Dialysis The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol) The Effect of Systemic Dietary Instruction on Management of Plasma Phosphorus Levels in Peritoneal Dialysis (PD) Patients Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia Long-term Effect of Lanthanum Carbonate on Bone Velphoro and Impact on the Oral Cavity and Gut Microbiome Phosphate Kinetic Modeling PA21 Safety and Efficacy in Adult Chinese Subjects The Influence of Dietary Phosphorus Education Program on Nutritional Status and Serum Phosphate Level Among Hemodialysis Patient Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone Safety and Tolerability Study of MCI-196 A Study of MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and Dyslipidaemia Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia The Effect of Magnesium Oxide on Plasma Phosphate in Hemodialysis Patients Fosrenol Post-marketing Surveillance in Japan Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia Fosrenol Post-marketing Surveillance for Continuous Cyclic Peritoneal Dialysis in Japan Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients Fosrenol Post-marketing Surveillance for Hemodialysis in Japan Long-term Study in Chronic Kidney Disease (Extension From Study 14817) Nicotinamide in Hemodialysis Patients With Hyperphosphatemia A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-based P Binders in Patients With Hyperphosphatemia A Study of HS219 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia Dose Finding Study to Treat High Phosphate Levels in the Blood. BAY 77-1931 Long-term Extension From Phase II Study Study of Individualized Therapy on Hyperphosphatemia in Maintenance Hemodialysis Patients A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis A Phase III Study of PA21 With Calcium Carbonate in Hemodialysis Patients With Hyperphosphatemia Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis Hyperphosphatemia in Children With Chronic Kidney Disease Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia Double Blind Randomized Placebo Controlled Trial of FOSTRAP Chewing Gum in Patients With CKD and Hyperphosphatemia A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD) A Phase III Study of PA21 in Peritoneal Dialysis Patients With Hyperphosphatemia An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD) A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In China Individualized Treatment of Hyperphosphatemia in Maintenance Hemodialysis Patients Open Study of BAY77-1931 (Lanthanum Carbonate) in Continuous Ambulatory Peritoneal Dialysis Patients Phase III Double-blind Comparative Study of BAY77-1931 (Lanthanum Carbonate) With Calcium Carbonate Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease Dose-finding Study of KHK7791 in Hyperphosphatemia Patients A Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on HD Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients The Efficacy of Niacin on Hyperphosphatemia in Patients Undergoing Haemodialysis A Phase 3 Study of Tenapanor to Treat Hyperphosphatemia in ESRD Patients on Dialysis A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia Nicotinic Acid in Hemodialysis Patients With Hyperphosphatemia